UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

Clinical pharmacology and therapeutics, 2014-10, Vol.96 (4), p.423-428

2014

Volltextzugriff (PDF)

Phenotype Standardization for Statin-Induced Myotoxicity

Clinical pharmacology and therapeutics, 2014-10, Vol.96 (4), p.470-476

2014

Volltextzugriff (PDF)

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

Clinical pharmacology and therapeutics, 2012-07, Vol.92 (1), p.112-117

2012

Volltextzugriff (PDF)

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

Clinical pharmacology and therapeutics, 2008-09, Vol.84 (3), p.326-331

2008

Volltextzugriff (PDF)

A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans

Clinical pharmacology and therapeutics, 2010-04, Vol.87 (4), p.445-451

2010

Volltextzugriff (PDF)

Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study

Lupus, 2019-12, Vol.28 (14), p.1640-1647

2019

Volltextzugriff (PDF)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

Clinical and translational science, 2017-05, Vol.10 (3), p.143-146

2017

Volltextzugriff (PDF)

129 United States Emergency Department Use of Medications with Pharmacogenetic Recommendations

Annals of emergency medicine, 2019-10, Vol.74 (4), p.S52-S52

2019

Volltextzugriff (PDF)

302 Biomarker Profiling for Obstructive Coronary Artery Disease: A PROMISE Substudy

Annals of emergency medicine, 2020-10, Vol.76 (4), p.S116-S116

2020

Volltextzugriff (PDF)

32EMF Isolating Micro-Ribonucleic Acids from Peripheral Plasma to Identify Myocardial Ischemia During Stress Testing in Emergency Department Patients

Annals of emergency medicine, 2018-10, Vol.72 (4), p.S16-S16

2018

Volltextzugriff (PDF)

99EMF Pilot of Integrated Metabolomic and MicroRNA Analysis to Identify Myocardial Ischemia on Emergency Department Cardiac Stress Tests

Annals of emergency medicine, 2019-10, Vol.74 (4), p.S40-S40

2019

Volltextzugriff (PDF)

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.877-886

2021

Volltextzugriff (PDF)

CV1 - A COST-EFFECTIVENESS ANALYSIS OF MULITI-GENE PHARMACOGENETIC TESTING IN ACUTE CORONARY SYNDROME PATIENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION

Value in health, 2018-10, Vol.21, p.S6-S6

2018

Volltextzugriff (PDF)

Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.785-796

2021

Volltextzugriff (PDF)

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

Pharmacogenomics and personalized medicine, 2015-01, Vol.8 (default), p.43-61

2015

Volltextzugriff (PDF)

Relationship Of Myocardial Necrosis, Inflammation And Coronary Atherosclerosis To Cardiovascular Outcomes In Patients With Stable Chest Pain: Results From The Promise Trial

Journal of cardiovascular computed tomography, 2020-07, Vol.14 (3), p.S83-S84

2020

Volltextzugriff (PDF)

The pharmacogenetics of coumarin therapy

Pharmacogenomics, 2005-07, Vol.6 (5), p.503-513

2005

Volltextzugriff (PDF)

Delivering pharmacogenetic testing in a primary care setting

Pharmacogenomics and personalized medicine, 2013-01, Vol.6 (default), p.105-112

2013

Volltextzugriff (PDF)

Repression of yeast Ste12 transcription factor by direct binding of unphosphorylated Kss1 MAPK and its regulation by the Ste7 MEK

Genes & development, 1998-09, Vol.12 (18), p.2887-2898

1998

Volltextzugriff (PDF)

The SLCO1B15 Genetic Variant Is Associated With Statin-Induced Side Effects

Journal of the American College of Cardiology, 2009-10, Vol.54 (17), p.1609-1616

2009

Volltextzugriff (PDF)

Effect of reduced inspired oxygen on fetal growth and maternal glucose metabolism in rat pregnancy

Metabolism, clinical and experimental, 1999-06, Vol.48 (6), p.738-744

1999

Volltextzugriff (PDF)

Differential regulation of transcription: repression by unactivated mitogen-activated protein kinase Kss1 requires the Dig1 and Dig2 proteins

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (26), p.15400-15405

1998

Volltextzugriff (PDF)

Clinical Application of Cardiovascular Pharmacogenetics

Journal of the American College of Cardiology, 2012-07, Vol.60 (1), p.9-20

2012

Volltextzugriff (PDF)

Aspirin Exposure Reveals Novel Genes Associated With Platelet Function and Cardiovascular Events

Journal of the American College of Cardiology, 2013-10, Vol.62 (14), p.1267-1276

2013

Volltextzugriff (PDF)

Is primary care ready for pharmacogenetics?

Pharmacogenomics, 2006-01, Vol.7 (1), p.1-3

2006

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(118)
magazinearticle
(1)

Sprache

Englisch
(106)
Französisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(48)
Humans
(42)
Female
(18)
Chemistry
(16)
Male
(16)
Physical Sciences
(15)
Aged
(14)
Chemistry, Physical
(14)
Pharmacogenetics
(14)
Pharmacology & Pharmacy
(14)
Physics
(14)
Cardiovascular System & Cardiology
(13)
Cardiac & Cardiovascular Systems
(12)
Patients
(12)
Middle Aged
(11)
Physics, Atomic, Molecular & Chemical
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Risk Factors
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

Phenotype Standardization for Statin-Induced Myotoxicity

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

A Polymorphism in the VKORC1 Regulator Calumenin Predicts Higher Warfarin Dose Requirements in African Americans

Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting

129 United States Emergency Department Use of Medications with Pharmacogenetic Recommendations

302 Biomarker Profiling for Obstructive Coronary Artery Disease: A PROMISE Substudy

32EMF Isolating Micro-Ribonucleic Acids from Peripheral Plasma to Identify Myocardial Ischemia During Stress Testing in Emergency Department Patients

99EMF Pilot of Integrated Metabolomic and MicroRNA Analysis to Identify Myocardial Ischemia on Emergency Department Cardiac Stress Tests

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing

CV1 - A COST-EFFECTIVENESS ANALYSIS OF MULITI-GENE PHARMACOGENETIC TESTING IN ACUTE CORONARY SYNDROME PATIENTS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION

Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting

Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

Relationship Of Myocardial Necrosis, Inflammation And Coronary Atherosclerosis To Cardiovascular Outcomes In Patients With Stable Chest Pain: Results From The Promise Trial

The pharmacogenetics of coumarin therapy

Delivering pharmacogenetic testing in a primary care setting

Repression of yeast Ste12 transcription factor by direct binding of unphosphorylated Kss1 MAPK and its regulation by the Ste7 MEK

The SLCO1B15 Genetic Variant Is Associated With Statin-Induced Side Effects

Effect of reduced inspired oxygen on fetal growth and maternal glucose metabolism in rat pregnancy

Differential regulation of transcription: repression by unactivated mitogen-activated protein kinase Kss1 requires the Dig1 and Dig2 proteins

Clinical Application of Cardiovascular Pharmacogenetics

Aspirin Exposure Reveals Novel Genes Associated With Platelet Function and Cardiovascular Events

Is primary care ready for pharmacogenetics?

Suchergebnisse filtern